Literature DB >> 25169742

Knockdown of NOB1 expression inhibits the malignant transformation of human prostate cancer cells.

Xiangmin Zhang1, Dongxu Zhang, Fajun Qu, Yi Hong, Jianwei Cao, Xiuwu Pan, Lin Li, Yi Huang, Hai Huang, Lei Yin, Lu Chen, Jizhong Ren, Zhijun Wang, Danfeng Xu, Xingang Cui.   

Abstract

Nin one binding-1 protein (NOB1) is a kind of zinc protein involved in ribosome biogenesis and controlled proteolysis. To explore the function of NOB1 in human prostate malignancy, we analyzed the expression of NOB1 in prostate cancer and found that NOB1 was elevated in prostate cancer tissues compared to the adjacent normal tissues. Knockdown of NOB1 by lentivirus-shRNA inhibited the proliferation and colony-formation ability of PC-3 and DU145 prostate cancer cells. Cell cycle analysis showed that silencing of NOB1 caused G0/G1 phase arrest and a slight decrease in S phase (P < 0.05). Furthermore, knockdown of NOB1 significantly suppressed the mobility of PC-3 and DU145 prostate cancer cells (P < 0.05). Collectively, these findings suggested that NOB1 might be involved in tumorigenecity of prostate cancer, and could be a potential molecular target for prostate cancer gene therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25169742     DOI: 10.1007/s11010-014-2126-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  22 in total

Review 1.  Therapeutic options for advanced prostate cancer: 2011 update.

Authors:  Aurelius Omlin; Johann S de Bono
Journal:  Curr Urol Rep       Date:  2012-04       Impact factor: 3.092

2.  Nob1 binds the single-stranded cleavage site D at the 3'-end of 18S rRNA with its PIN domain.

Authors:  Allison C Lamanna; Katrin Karbstein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-14       Impact factor: 11.205

3.  Downregulation of NIN/RPN12 binding protein inhibit the growth of human hepatocellular carcinoma cells.

Authors:  Zaiming Lu; Qiyong Guo; Aizhong Shi; Feng Xie; Qingjie Lu
Journal:  Mol Biol Rep       Date:  2011-05-15       Impact factor: 2.316

4.  siRNA mediated silencing of NIN1/RPN12 binding protein 1 homolog inhibits proliferation and growth of breast cancer cells.

Authors:  Wei-Yi Huang; Dong-Hui Chen; Li Ning; Li-Wei Wang
Journal:  Asian Pac J Cancer Prev       Date:  2012

5.  RNA interference-mediated silencing of eukaryotic translation initiation factor 3, subunit B (EIF3B) gene expression inhibits proliferation of colon cancer cells.

Authors:  Zheng Wang; Jinxian Chen; Jianhua Sun; Zhe Cui; Hui Wu
Journal:  World J Surg Oncol       Date:  2012-06-26       Impact factor: 2.754

6.  Cloning, expression and characterization of the human NOB1 gene.

Authors:  Yue Zhang; Jun Ni; Guangjin Zhou; Jian Yuan; Weihua Ren; Yuxi Shan; Wenwen Tang; Long Yu; Shouyuan Zhao
Journal:  Mol Biol Rep       Date:  2005-09       Impact factor: 2.316

Review 7.  Therapeutic options in androgen-independent prostate cancer: building on docetaxel.

Authors:  Daniel Petrylak
Journal:  BJU Int       Date:  2005-12       Impact factor: 5.588

8.  Nob1p is required for biogenesis of the 26S proteasome and degraded upon its maturation in Saccharomyces cerevisiae.

Authors:  Yoshiko Tone; Akio Toh-E
Journal:  Genes Dev       Date:  2002-12-15       Impact factor: 11.361

9.  Structural and functional analysis of the archaeal endonuclease Nob1.

Authors:  Thomas Veith; Roman Martin; Jan P Wurm; Benjamin L Weis; Elke Duchardt-Ferner; Charlotta Safferthal; Raoul Hennig; Oliver Mirus; Markus T Bohnsack; Jens Wöhnert; Enrico Schleiff
Journal:  Nucleic Acids Res       Date:  2011-12-10       Impact factor: 16.971

10.  Anti-neoplastic properties of hydralazine in prostate cancer.

Authors:  Inês Graça; Elsa J Sousa; Pedro Costa-Pinheiro; Filipa Q Vieira; Jorge Torres-Ferreira; Maria Gabriela Martins; Rui Henrique; Carmen Jerónimo
Journal:  Oncotarget       Date:  2014-08-15
View more
  7 in total

1.  MicroRNA-215 targets NOB1 and inhibits growth and invasion of epithelial ovarian cancer.

Authors:  Yang Lin; Yang Jin; Tianmin Xu; Shunqing Zhou; Manhua Cui
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

2.  miRNA-612 suppresses ovarian cancer cell tumorigenicity by downregulating NOB1.

Authors:  Zhikun Shi; Xu Zhou; Meijing Bao; Rongxia Jia; Yuqing Chu; Yang Lin
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

3.  Anticancer activity of NOB1-targeted shRNA combination with TRAIL in epithelial ovarian cancer cells.

Authors:  Yang Lin; Tianmin Xu; Hong Teng; Manhua Cui
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  MicroRNA-363 inhibits ovarian cancer progression by inhibiting NOB1.

Authors:  Yang Lin; Tianmin Xu; Shunqing Zhou; Manhua Cui
Journal:  Oncotarget       Date:  2017-09-30

5.  LncRNA OIP5-AS1 Promotes the Proliferation of Hemangioma Vascular Endothelial Cells via Regulating miR-195-5p/NOB1 Axis.

Authors:  Jiayu Zhang; Tiancheng Zhao; Leilei Tian; Yezhou Li
Journal:  Front Pharmacol       Date:  2019-04-24       Impact factor: 5.810

6.  MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.

Authors:  Yongtao Zhang; Fang Wang; Lina Wang; Quanbin Zhang
Journal:  World J Surg Oncol       Date:  2020-05-01       Impact factor: 2.754

7.  Low-level miR-646 in colorectal cancer inhibits cell proliferation and migration by targeting NOB1 expression.

Authors:  Huajia Dai; Kezhu Hou; Zujin Cai; Qi Zhou; Song Zhu
Journal:  Oncol Lett       Date:  2017-09-22       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.